196811-12-8Relevant articles and documents
N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent
Cobb, Jeff E.,Blanchard, Steven G.,Boswell, Evan G.,Brown, Kathleen K.,Charifson, Paul S.,Cooper, Joel P.,Collins, Jon L.,Dezube, Milana,Henke, Brad R.,Hull-Ryde, Emily A.,Lake, Debra H.,Lenhard, James M.,Oliver Jr., William,Oplinger, Jeffery,Pentti, Mila,Parks, Derek J.,Plunket, Kelli D.,Tong, Wei-Qin
, p. 5055 - 5069 (2007/10/03)
3-{4-[2-(Benzoxazol-2-ylmethylamino)ethoxy]phenyl}-(2S)-((2- benzoylphenyl)amino)propionic acid (1) and (2S)-((2-benzoylphenyl)amino)-3- {4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenyl}propionic acid (2) are peroxisome proliferator-activated receptor γ